These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 8750247)

  • 1. Trials of the effects of drugs and hormones on lipids and lipoproteins.
    Mann WA; Windler E; Beil FU; Greten H
    Curr Opin Lipidol; 1995 Dec; 6(6):354-9. PubMed ID: 8750247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Nicotinic acid and the derivative].
    Ogaki S; Matsushima T
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():637-41. PubMed ID: 11347146
    [No Abstract]   [Full Text] [Related]  

  • 3. Reducing cardiac deaths with hypolipidemic drugs.
    Naito HK
    Postgrad Med; 1987 Nov; 82(6):102-12. PubMed ID: 3313343
    [No Abstract]   [Full Text] [Related]  

  • 4. Niacin as a component of combination therapy for dyslipidemia.
    Miller M
    Mayo Clin Proc; 2003 Jun; 78(6):735-42. PubMed ID: 12934785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiographic trials of lipid-lowering therapy: an update.
    Mancini GB
    Curr Opin Lipidol; 1995 Dec; 6(6):379-85. PubMed ID: 8750252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selection of appropriate type and intensity of lipid-lowering therapy.
    Tikkanen MJ
    Curr Opin Lipidol; 1995 Dec; 6(6):360-4. PubMed ID: 8750248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipoprotein disorders in women: which women are the best candidates for hormone replacement therapy?
    Plushner SL
    Ann Pharmacother; 1997 Jan; 31(1):98-107. PubMed ID: 8997474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treating mixed dyslipidemias: why and how.
    Ballantyne CM
    Clin Cardiol; 2001; 24(7 Suppl):II-6-9. PubMed ID: 11444652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of a lipid lowering fibrate and hormone replacement therapy on serum lipids and lipoproteins in overweight postmenopausal women with elevated triglycerides.
    Nerbrand C; Nyberg P; Nordström L; Samsioe G
    Maturitas; 2002 May; 42(1):55-62. PubMed ID: 12020980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of diabetic dyslipidemia.
    Garg A
    Am J Cardiol; 1998 Feb; 81(4A):47B-51B. PubMed ID: 9526814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapy and clinical trials.
    Seed M
    Curr Opin Lipidol; 1996 Oct; 7(5):U168-72. PubMed ID: 8937532
    [No Abstract]   [Full Text] [Related]  

  • 12. Trials of lipid-lowering therapy in secondary prevention of coronary heart disease.
    Olsson AG; Pedersen T; Bergdahl B
    Curr Opin Lipidol; 1995 Dec; 6(6):369-73. PubMed ID: 8750250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Probucol].
    Yagyu H
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():631-6. PubMed ID: 11347145
    [No Abstract]   [Full Text] [Related]  

  • 14. Niacin: a powerful adjunct to other lipid-lowering drugs in reducing plaque progression and acute coronary events.
    Davidson MH
    Curr Atheroscler Rep; 2003 Sep; 5(5):418-22. PubMed ID: 12911853
    [No Abstract]   [Full Text] [Related]  

  • 15. Niacin for dyslipidemia: considerations in product selection.
    McKenney J
    Am J Health Syst Pharm; 2003 May; 60(10):995-1005. PubMed ID: 12789870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medical management of hyperlipidemia and the role of probucol.
    Davignon J
    Am J Cardiol; 1986 Jun; 57(16):22H-28H. PubMed ID: 3460320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid-lowering drugs.
    Milander MM; Kuhn M
    AACN Clin Issues Crit Care Nurs; 1992 May; 3(2):494-506. PubMed ID: 1576043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of once-daily, niacin extended-release/lovastatin with standard doses of atorvastatin and simvastatin (the ADvicor Versus Other Cholesterol-Modulating Agents Trial Evaluation [ADVOCATE]).
    Bays HE; Dujovne CA; McGovern ME; White TE; Kashyap ML; Hutcheson AG; Crouse JR;
    Am J Cardiol; 2003 Mar; 91(6):667-72. PubMed ID: 12633795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacology department: pharmacologic approaches to abnormal blood lipids.
    Gylys KH
    J Cardiovasc Nurs; 2000 Jan; 14(2):9-15. PubMed ID: 10653272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The reduction of dyslipidemia and oxidative stress in experimental diabetes mellitus treated with probucol].
    Colev V; Păduraru I; Vornicu M; Bădescu M; Mocanu V; Ciocoiu M; Saramet A; Bohotin C
    Rev Med Chir Soc Med Nat Iasi; 1997; 101(1-2):103-7. PubMed ID: 10756736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.